Metraipolis › archive › dc_264e98e35663
Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study — Europe PMC PMID:42149363
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42149363
- DOI
- 10.1007/s15010-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T15:40:25.929Z
- SHA-256 of the archived text
cf957ac45bf1b375aa8134e5efd0395f5c2d5d139c2e3883beadbba56456b2c3- Stable URL of this page
https://metraipolis.com/documento/dc_264e98e35663
How to cite
Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study — Europe PMC PMID:42149363 — Europe PMC (en), https://europepmc.org/article/MED/42149363 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_264e98e35663 (Metraipolis archive dc_264e98e35663, sha256 cf957ac45bf1b375aa8134e5efd0395f5c2d5d139c2e3883beadbba56456b2c3)
BibTeX
@misc{dc264e98e35663,
title = {Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study — Europe PMC PMID:42149363},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42149363},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_264e98e35663; sha256 cf957ac45bf1b375aa8134e5efd0395f5c2d5d139c2e3883beadbba56456b2c3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42149363. Agents can read the archived copy with the MCP tool read_document.